Ask AI
ProCE Banner Activity

Navigating Optimal Care for Older Adults With HR+/HER2- Metastatic Breast Cancer: Practical Strategies for Overcoming Clinical Barriers

Clinical Thought

For older adults with HR-positive/HER2-negative metastatic breast cancer, success depends on individualizing therapy based on each patient’s medical needs and goals in care. Practical approaches to geriatric assessment, drug toxicity monitoring, and personalized dosing titration can help us tackle the challenge of translating clinical data into day-to-day decisions for effective, tolerable care.

Released: September 02, 2025

Continue Activity View Activity

Share

Provided by

Provided by Clinical Care Options, LLC In partnership with Smart Patients, Inc.

ProCE Banner

Supporters

Supported by an educational grant from Pfizer Inc.

Pfizer Inc.

Partners

Smart Patients

ProCE Banner

Faculty Disclosure

Primary Author

Erika Hamilton, MD, FASCO: researcher (paid to institution): AbbVie, Accutar Biotechnology, Artios, Arvinas, AstraZeneca, AtlasMedx, BeiGene, BeOne, Bicycle, Biohaven, BioNTech, Compugen, Cullinan, Daiichi Sankyo, Dantari, Day One Biopharmaceuticals, Duality Biologics, Ellipses, Elucida Oncology, Exelixis, FujiFilm, Genmab, Gilead, H3 Biomedicine, Iambic Therapeutics, Immunogen, Inspirna, InventisBio, Jacobio, Jazz, K-Group Beta, Kind, Lilly, Loxo Oncology, Mabspace, Mabwell, Marengo, MediLink, Merck, Mersana, Novartis, Olema, Orinove, Orum, Pfizer, Pionyr, Prelude, Profound Bio, Regeneron, Relay, Rgenix, Roche/Genentech, SeaGen, Shattuck Labs, Simcha, Stemline, Sutro, Systimmune, Taiho, Tesaro, TheRas, Treadwell, Verastem, Xadcera, Zymeworks; consultant/advisor (paid to institution): Arvinas, AstraZeneca, BeOne, BioNTech, Boehringer Ingelheim, Boundless Bio, Bristol Myers Squibb, Circle, Daiichi Sankyo, Gilead, Halda, Incyclix, IQVIA, Janssen, Jazz, Jefferies, Johnson & Johnson, Lilly, Mersana, Novartis, Pfizer, Precede, Pyxis Oncology, Roche/Genentech, Samsung Bioepis, Shorla, Stemline, Tempus.